Gene therapy pioneer Jim Wilson's fight against the ‘great abandonment’

Plus: The FDA approved updated Covid-19 vaccines, shots should be available in days

August 22, 2024 Check out STAT+

Sponsored By

EMILIE PICKERING FOR STAT STAT+ | Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate As other firms are 'walking away, we can lean into this,' Wilson tells STAT, discussing launch of Gemma Biotherapeutics and Franklin Biolabs By Jonathan Wosen FDA approves updated Covid-19 vaccines, shots should be available in days Pfizer and Moderna are set to begin shipping millions of doses. Novavax expects its updated vaccine version to be available a little later. By Associated Press Columbia medical school gets $400 million gift to fund long-shot basic research Former Merck chair and CEO Roy Vagelos and his wife, Diana, have donated total of $900 million to Columbia By Usha Lee McFarling Samuel Corum/Getty Images Oprah, Walz and other Democrats hammer reproductive freedom message at DNC Night 3 of the Democrats' convention featured advocates who hammered the need to protect access to abortion and fertility treatments. By Rachel Cohrs Zhang STAT+ | Digital therapeutics pioneer Pear's treatments get a second life, a year after bankruptcy Pear Therapeutics filed for bankruptcy in late 2023, but its smartphone apps for treating substance use disorder are now back on the market. By Mario Aguilar STAT+ | U.K.'s cost-effectiveness agency gives negative review of Alzheimer's drug Leqembi The review from the U.K.'s cost-effectiveness watchdog means the Alzheimer's therapy wouldn't be available through the NHS. By Andrew Joseph Adobe STAT+ | Tome Biosciences, once a high-flying gene-editing startup, is floundering The company announced in December that it had raised $213 million to fund what it called the "final chapter in genomic medicines." By Jason Mast and Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser